Deal case Bulge bracket M&A superday, Merrow Medical
Merrow Medical's board received a $41.00 per share cash offer and asked our firm for a fairness opinion. Merrow has $150 million of LTM EBITDA, $300 million of net debt, and 40 million shares; the unaffected price was $33.00. Build the missing bars of the football field and tell the board whether the price is fair.
Written by Waddle Street. The company and every number are made up for practice.
Run it as a mock with an interviewer who follows up.